Keywords : Black Fungus
A Comparative Study Of Diabetic And Non-Diabetic With Covid-19 Associated Mucormycosis
European Journal of Molecular & Clinical Medicine,
2023, Volume 10, Issue 1, Pages 3957-3964
Aim: The COVID-19 global pandemic had resulted in a rise in a spike of Mucormycosis (black fungus) in COVID-19 individuals and diabetes is a standalone risk factor for both severe COVID-19 and black fungus, especially in India. We sought to find out how often CAM (Covid 19-associated Mucormycosis) was among both diabetes and non-diabetic individuals.
Method: The data was gathered from Kaushik pathology Lab, Barara, Ambala, Haryana. The study includes 300 patients divided into 2 groups. Both the groups comprise of 150 patients each. Group 1 consist of patients with diabetes whereas group 2 comprise of non-diabetic patients. Prevalence of CAM was then noted in both the groups.
Result: The study showed that in group 1, 74.4% cases were reported as CAM and 25.6% cases were identified as non-CAM whereas in group 2, only 38.4% CAM cases were reported in non-diabetic patients and majority of them (61.6%) were evaluated as non-CAM. A significant difference was also observed between the prevalence rate of both the groups (P < 0.05).
Conclusion: A significant difference in the CAM cases of both the groups was observed. Interestingly diabetic patients were found to be more prevalent to be infected with CAM. Further, it was concluded that New-onset diabetes was the predominant risk factor for CAM in our study. COVID-19 being other important ones for Mucormycosis in COVID-19 patients.